Persistent C-Peptide Levels and Proliferative Retinopathy in Childhood-Onset Type 1 Diabetes (T1D)

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 589-P
Author(s):  
KATHERINE WILLIAMS ◽  
TINA COSTACOU ◽  
DOROTHY J. BECKER ◽  
TREVOR J. ORCHARD
Diabetologia ◽  
2006 ◽  
Vol 49 (10) ◽  
pp. 2281-2290 ◽  
Author(s):  
T. Skrivarhaug ◽  
D. S. Fosmark ◽  
L. C. Stene ◽  
H.-J. Bangstad ◽  
L. Sandvik ◽  
...  

2019 ◽  
Vol 33 (9) ◽  
pp. 657-661 ◽  
Author(s):  
Katherine V. Williams ◽  
Dorothy J. Becker ◽  
Trevor J. Orchard ◽  
Tina Costacou

2014 ◽  
Author(s):  
Suma Uday ◽  
James Yong ◽  
Fiona Campbell ◽  
Ramzi Ajjan

Diabetes Care ◽  
2017 ◽  
Vol 41 (3) ◽  
pp. 420-425 ◽  
Author(s):  
Vibeke Gagnum ◽  
Maryam Saeed ◽  
Lars C. Stene ◽  
Torbjørn Leivestad ◽  
Geir Joner ◽  
...  

Diabetes Care ◽  
2000 ◽  
Vol 23 (3) ◽  
pp. 290-294 ◽  
Author(s):  
T. Podar ◽  
A. Solntsev ◽  
A. Reunanen ◽  
B. Urbonaite ◽  
R. Zalinkevicius ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Andrzej S. Januszewski ◽  
Yoon Hi Cho ◽  
Mugdha V. Joglekar ◽  
Ryan J. Farr ◽  
Emma S. Scott ◽  
...  

AbstractThe aim of this cross-sectional study was to compare plasma C-peptide presence and levels in people without diabetes (CON) and with Type 1 diabetes and relate C-peptide status to clinical factors. In a subset we evaluated 50 microRNAs (miRs) previously implicated in beta-cell death and associations with clinical status and C-peptide levels. Diabetes age of onset was stratified as adult (≥ 18 y.o) or childhood (< 18 y.o.), and diabetes duration was stratified as ≤ 10 years, 10–20 years and > 20 years. Plasma C-peptide was measured by ultrasensitive ELISA. Plasma miRs were quantified using TaqMan probe-primer mix on an OpenArray platform. C-peptide was detectable in 55.3% of (n = 349) people with diabetes, including 64.1% of adults and 34.0% of youth with diabetes, p < 0.0001 and in all (n = 253) participants without diabetes (CON). C-peptide levels, when detectable, were lower in the individuals with diabetes than in the CON group [median lower quartile (LQ)–upper quartile (UQ)] 5.0 (2.6–28.7) versus 650.9 (401.2–732.4) pmol/L respectively, p < 0.0001 and lower in childhood versus adult-onset diabetes [median (LQ–UQ) 4.2 (2.6–12.2) pmol/L vs. 8.0 (2.3–80.5) pmol/L, p = 0.02, respectively]. In the childhood-onset group more people with longer diabetes duration (> 20 years) had detectable C-peptide (60%) than in those with shorter diabetes duration (39%, p for trend < 0.05). Nine miRs significantly correlated with detectable C-peptide levels in people with diabetes and 16 miRs correlated with C-peptide levels in CON. Our cross-sectional study results are supportive of (a) greater beta-cell function loss in younger onset Type 1 diabetes; (b) persistent insulin secretion in adult-onset diabetes and possibly regenerative secretion in childhood-onset long diabetes duration; and (c) relationships of C-peptide levels with circulating miRs. Confirmatory clinical studies and related basic science studies are merited.


2015 ◽  
Vol 169 (12) ◽  
pp. e153759 ◽  
Author(s):  
Maria C. Magnus ◽  
Sjurdur F. Olsen ◽  
Charlotta Granström ◽  
Geir Joner ◽  
Torild Skrivarhaug ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document